Dr. Loaiza-Bonilla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Capital Way
Capital Health Cancer Center
Pennington, NJ 08534Phone+1 609-537-6363- Is this information wrong?
Summary
- Dr. Arturo Loaiza-Bonilla is an oncologist in Pennington, NJ and is affiliated with Capital Health. He also speaks multiple languages, including French, Spanish, Japanese. He specializes in cancer genetics/cancer risk assessment, gastrointestinal cancer, and hematologic oncology and is experienced in immunotherapy, clinical molecular genetics, clinical research, AI, digital and global health.
Education & Training
- University of PennsylvaniaMSEd, Medical Education, 2014 - 2016
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2010 - 2013
- Johns Hopkins University School of MedicinePost-Doctoral Fellowship, Medicine - Hematology and Oncology, 2007 - 2010
- MedStar Health/Harbor HospitalResidency, Internal Medicine, 2007 - 2010
- National University of ColombiaClass of 2004
Certifications & Licensure
- NJ State Medical License 2022 - 2025
- PA State Medical License 2013 - 2024
- GA State Medical License 2021 - 2022
- FL State Medical License Active through 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top 40 Under 40 Philadelphia Business Journal, 2018
- Castle Connolly Top Doctor Recognition Castle Connolly, 2018
- President Elect Pennsylvania Society of Oncology and Hematology, 2018
- Join now to see all
Clinical Trials
- A Study of TAS-120 in Patients With Advanced Solid Tumors Start of enrollment: 2014 Jul 21
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Start of enrollment: 2016 Mar 14
- Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer Start of enrollment: 2017 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Achieving white blood cell equity: are the safety profiles of biosimilar and reference pegfilgrastims comparable?Arturo Loaiza-Bonilla, Ray D Page> ;Future Oncology. 2024 Jan 1
- 5 citationsClinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US:Ran Jin, Reshma Mahtani, Neil A. Accortt, Tatiana Lawrence, Darcie Sandschafer, Arturo Loaiza-Bonilla> ;Therapeutic Advances in Medical Oncology. 2021 Sep 1
- 208 citationsAssociation of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.Petros Grivas, Ali Raza Khaki, Trisha Wise-Draper, Benjamin French, C. Hennessy, Chih-Yuan Hsu, Yu Shyr, X. Li, Toni K. Choueiri, Corrie A. Painter, Solange Peters, Br...> ;Annals of Oncology. 2021 Jun 1
- Join now to see all
Press Mentions
- Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient CareMarch 22nd, 2023
- Clinical Trials Demystified by Massive Bio’s Chief Medical OfficerFebruary 28th, 2023
- Massive Bio Announces Plans to Expand AI Use in Oncology, from Clinical Trial Matching to Drug Matching and BeyondJanuary 5th, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
Other Languages
- French, Spanish, Japanese
External Links
- LinkedInhttps://www.linkedin.com/in/arturoloaizabonillla
- CTCA websitehttps://www.cancercenter.com/eastern/doctors-and-clinicians/arturo-loaiza-bonilla/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: